News Focus
News Focus
Post# of 257267
Next 10
Followers 843
Posts 122806
Boards Moderated 10
Alias Born 09/05/2002

Re: DewDiligence post# 210224

Thursday, 09/07/2017 2:57:58 PM

Thursday, September 07, 2017 2:57:58 PM

Post# of 257267
ABBV reports positive phase-2b data for Upadacitinib in atopic dermatitis:

https://finance.yahoo.com/news/abbvies-upadacitinib-abt-494-meets-120300696.html

Upadacitinib (f/k/a ABT-494) is an oral JAK1 inhibitor.

“The efficient-market hypothesis may be
the foremost piece of B.S. ever promulgated
in any area of human knowledge!”

Discover What Traders Are Watching

Explore small cap ideas before they hit the headlines.

Join Today